Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug hepatotoxicity.

Zachary D Goodman1

  • 1Division of Hepatic Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Room 3107, 14th Street and Alaska Avenue, NW, Washington, DC 20306, USA. goodman@afip.osd.mil

Clinics in Liver Disease
|July 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials.

Journal of hepatology·2025
Same author

Making Sense of 'Porto-Sinusoidal Vascular Disorder': What Does It Mean for the Pathologist and the Patient?

Liver international : official journal of the International Association for the Study of the Liver·2024
Same author

Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma.

Human pathology·2024
Same author

Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.

Alimentary pharmacology & therapeutics·2024
Same author

Severe acute liver disease in adults: Contemporary role of histopathology.

Histopathology·2024
Same author

A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.

Hepatology (Baltimore, Md.)·2023
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Drug-induced liver disease is a common cause of liver injury that is often missed. Diagnosing drug hepatotoxicity requires high suspicion and correlating biopsy findings with clinical data.

Area of Science:

  • Hepatology
  • Toxicology
  • Pathology

Background:

  • Drug-induced liver disease (DILD) is a frequent yet underdiagnosed cause of liver injury.
  • Drugs can mimic various clinical presentations and histopathological findings, complicating diagnosis.
  • Accurate diagnosis relies on clinical suspicion and comprehensive data correlation.

Purpose of the Study:

  • To highlight the diagnostic challenges of drug-induced liver disease.
  • To emphasize the importance of clinical suspicion and data correlation in diagnosing DILD.
  • To provide guidance on approaching liver biopsies in undiagnosed liver disease.

Main Methods:

  • Review of diagnostic criteria for drug hepatotoxicity.
  • Correlation of histopathological findings with clinical and laboratory data.

Related Experiment Videos

  • Literature search for precedents in drug-induced liver injury cases.

    • Main Results:

    • Drug-induced liver disease is often unrecognized due to its varied presentations.
    • Diagnosis requires a high index of suspicion.
    • Histopathological findings must be correlated with clinical and laboratory data.

    Conclusions:

    • Diagnosing drug hepatotoxicity necessitates a proactive clinical approach.
    • Comprehensive correlation of histopathology, clinical presentation, and laboratory results is crucial.
    • Consulting medical literature for similar cases aids in confirming drug-induced liver injury.